Skip to main content
. 2015 Jul 14;6(29):27566–27579. doi: 10.18632/oncotarget.4491

Figure 4. Neuroendocrine carcinoma of the colon ascendens (G3, Ki-67: 80%); immunohistochemistry, counterstaining with hematoxylin; original magnification: x400.

Figure 4